End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
NCT01386723
·
clinicaltrials.gov ↗
TERMINATED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenia
Interventions
DRUG:
Discontinuation of eltrombopag
Sponsor
Weill Medical College of Cornell University
Collaborators
[object Object]